MAZE News
Archived Headlines
- Precision medicine biotech Maze Therapeutics sets terms for $125 million IPO 01/27/25
- US IPO Week Ahead: Meat, oil, and more set to debut in 5 IPO week 01/24/25
- US IPO Weekly Recap: Flowco launches first major IPO of 2025 as Smithfield, others join the pipeline 01/10/25
- Precision medicine biotech Maze Therapeutics files for a $100 million IPO 01/07/25
Bigger Biotechs: IPO valuations have soared for drug developers over the past decade
New biotech issuers have doubled in size over the past decade.Last year, the average biotech IPO went public at a market cap of $644 million, compared to $318 million a decade earlier, for deals raising at least $20 million. The average wasn’t skewed by a ...read more
US IPO Weekly Recap: Active January closes out with several sizable IPOs
Five IPOs listed this week, all of which raised over $100 million. One direct listing and three SPACs also debuted. Four IPOs and three SPACs submitted initial filings.Leading meat products producer Smithfield Foods (SFD) priced its downsized IPO below the...read more
Precision medicine biotech Maze Therapeutics prices upsized IPO at the $16 midpoint
Maze Therapeutics, a Phase 2 biotech developing precision small molecule therapies for kidney disease, raised $140 million by offering 8.8 million shares at $16, within the range of $15 to $17. The company offered 1 million more shares than anticipated.Maze...read more
Sizable IPO filings reach a three-year high amid steady stream of deals
The 2025 IPO market has kicked off with a steady stream of large deals, and new filing activity signals more to come. Thirteen IPOs planning to raise $100 million or more have joined the pipeline, the most in a single month since January 2022....read more